Literature DB >> 28404208

Predictors of physicians' communication performance in a decision-making encounter with a simulated advanced-stage cancer patient: A longitudinal study.

Yves Libert1, Delphine Canivet2, Catherine Ménard3, Laëtitia Van Achte4, Christine Farvacques5, Isabelle Merckaert6, Aurore Liénard3, Jean Klastersky3, Christine Reynaert4, Jean-Louis Slachmuylder5, Jean-François Durieux5, Nicole Delvaux7, Darius Razavi6.   

Abstract

OBJECTIVES: Physicians' characteristics that influence their communication performance (CP) in decision-making encounters have been rarely studied. In this longitudinal study, predictors of physicians' CP were investigated with a simulated advanced-stage cancer patient.
METHODS: Physicians (n=85) performed a decision-making encounter with a simulated patient (SP). Their CP was calculated by analyzing encounter transcripts with validated interaction analysis systems. Potential specific psychological predictors were physicians' empathy towards the SP (Jefferson Scale of Physician Empathy, JSPE) and their decisional conflict about the treatment (Decisional Conflict Scale, DCS). Potential general psychological predictors were physicians' empathy towards cancer patients (JSPE), their decisional conflict about cancer patients' treatments (DCS), and their affective reactions to uncertainty (Physicians' Reactions to Uncertainty, PRU).
RESULTS: Physicians' CP was predicted by their decisional conflict about the SP's treatment (DCS) (β=0.41; p< 0.001) and their affective reactions to uncertainty regarding cancer treatments (PRU) (β=-0.31; p=0.003).
CONCLUSION: During encounters with advanced-stage cancer patients, physicians' awareness of uncertainty about which treatments to consider may facilitate their communication performance, whereas physicians' affective reactions to uncertainty may inhibit their performance. PRACTICE IMPLICATIONS: Physicians' decisional conflict and reactions to uncertainty should be addressed in communication skills training programs.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Communication; Decision-making; Physicians; Psychological predictors; Simulated patient

Mesh:

Year:  2017        PMID: 28404208     DOI: 10.1016/j.pec.2017.02.025

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  4 in total

1.  Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial.

Authors:  Inge Henselmans; Hanneke W M van Laarhoven; Hanneke C J M de Haes; Meltem Tokat; Ellen G Engelhardt; Pomme E A van Maarschalkerweerd; Marleen Kunneman; Petronella B Ottevanger; Serge E Dohmen; Geert-Jan Creemers; Dirkje W Sommeijer; Filip Y F L de Vos; Ellen M A Smets
Journal:  Oncologist       Date:  2018-06-29

2.  Communication about uncertainty and hope: A randomized controlled trial assessing the efficacy of a communication skills training program for physicians caring for cancer patients.

Authors:  Yves Libert; Livia Peternelj; Isabelle Bragard; Aurore Liénard; Isabelle Merckaert; Christine Reynaert; Darius Razavi
Journal:  BMC Cancer       Date:  2017-07-10       Impact factor: 4.430

3.  Decisional conflict of physicians during the decision-making process for a simulated advanced-stage cancer patient: an international longitudinal study with German and Belgian physicians.

Authors:  Catharina Schoenfeld; Yves Libert; Heribert Sattel; Delphine Canivet; France Delevallez; Andreas Dinkel; Pascal O Berberat; Alexander Wuensch; Darius Razavi
Journal:  BMC Cancer       Date:  2018-11-23       Impact factor: 4.430

4.  Psychometric properties of the Shared Decision-Making Questionnaire (SDM-Q-9) in oncology practice.

Authors:  Caterina Calderon; Paula Jiménez-Fonseca; Pere Joan Ferrando; Carlos Jara; Urbano Lorenzo-Seva; Carmen Beato; Teresa García-García; Beatriz Castelo; Avinash Ramchandani; María Mar Muñoz; Eva Martínez de Castro; Ismael Ghanem; Montse Mangas; Alberto Carmona-Bayonas
Journal:  Int J Clin Health Psychol       Date:  2018-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.